Ticker
TVTXCompany Name
TRAVERE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 555.31M | $ 323.49M | 58.25% |
3/31/2025 | $ 548.8M | $ 262.61M | 47.85% |
12/31/2024 | $ 594.13M | $ 225.43M | 37.94% |
9/30/2024 | $ 504.41M | $ 193.69M | 38.4% |
6/30/2024 | $ 551.12M | $ 168.23M | 30.52% |
3/31/2024 | $ 663.55M | $ 173.88M | 26.2% |
12/31/2023 | $ 788.91M | $ 133.79M | 16.96% |
9/30/2023 | $ 832.85M | $ 199.52M | 23.96% |
6/30/2023 | $ 736.43M | $ 215.54M | 29.27% |
3/31/2023 | $ 808.23M | $ 209.94M | 25.98% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for TRAVERE THERAPEUTICS INC is calculated as follows: GP [ $ 188.25M ] / Assets [ $ 692.22M ]
(=) GPA [ 27.19% ]
Minimum
Dec 31, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.15% |
median | 15.35% |
std | 19.95% |